Navigation Links
Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
Date:5/7/2008

1,493 3,524

Interest expense, net (572) (624)

Total other income 2,520 3,214

Net loss $(3,942) $(3,888)

Net loss per share, basic $(0.13) $(0.14)

Net loss per share, diluted $(0.13) $(0.26)

Weighted average shares

outstanding, basic 30,336,928 28,311,744

Weighted average shares

outstanding, diluted 30,336,928 28,618,574

EMISPHERE TECHNOLOGIES, INC.

CONDENSED BALANCE SHEETS

March 31, 2008 and December 31, 2007

(in thousands, except share and per share data)

March 31, December 31,

2008 2007

(unaudited)

Assets:

Current assets:

Cash, cash equivalents, and investments $9,858 $13,854

Accounts receivable 127 240

Prepaid expenses and other current assets 828 1,035

Total current assets 10,813 15,129

Equipment and leasehold improvements, net 1,946 2,074

Purchased technology, net 1,495 1,555

Restricted cash 246 246

Other assets 465 477

Total assets $14,965 $19,481

Liabilities and Stockholders' Deficit:

Current liabilities $3,832 $5,507

Notes payable
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results
2. Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
3. Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008
4. Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results
5. Emisphere Technologies, Inc. Announces Conference Call for 2007 Fourth Quarter and Year End Financial Results
6. Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12
7. Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
8. Emisphere to Host Business Strategy Conference Call on February 7
9. Emisphere Technologies, Inc. Moves Into New Corporate Headquarters
10. Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
11. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... newly developed Bruton,s tyrosine kinase (BTK) inhibitor for ... results of these preclinical evaluations have been communicated ... feedback received from the Agency is supportive of ... preclinical work is required to begin a Phase ...
(Date:2/27/2015)... Australia , Feb. 27, 2015 Bionomics ... from the DisrupTOR-1 trial of BNC105 in patients with ... in Orlando, Florida . The data ... of the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and ...
(Date:2/27/2015)... 2015   PureTech , a science and technology ... products and technologies in the healthcare sector, announced today ... and Member of the Board of Directors of Sanofi, ... has been a pleasure to know Chris for many ... be working together more closely now," said Dr. ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates for central nervous system disorders, today announced ... March 31, 2009. Vanda reported a net loss ... compared to $7.5 million for the fourth quarter of ...
... Mass., April 29 LaVoie Group, a life ... has been selected as public relations agency of ... Inc. Donna L. LaVoie, President & CEO of ... Profectus during an important stage in the company,s ...
... billions in pest losses annually , ... St. Louis, MO (PRWEB) April ... Divergence, Inc. , has received more than $1.2 million in research grants, ... to further the company,s work on biotech traits for lesion nematode control ...
Cached Biology Technology:Vanda Pharmaceuticals Reports First Quarter 2009 Results 2Vanda Pharmaceuticals Reports First Quarter 2009 Results 3Vanda Pharmaceuticals Reports First Quarter 2009 Results 4Vanda Pharmaceuticals Reports First Quarter 2009 Results 5Vanda Pharmaceuticals Reports First Quarter 2009 Results 6Vanda Pharmaceuticals Reports First Quarter 2009 Results 7Vanda Pharmaceuticals Reports First Quarter 2009 Results 8Vanda Pharmaceuticals Reports First Quarter 2009 Results 9Vanda Pharmaceuticals Reports First Quarter 2009 Results 10LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record 2Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn 2Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn 3
(Date:3/2/2015)... 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced a new implementation of its ... rapid and secure transactions and reliable identification for ... a turnkey solution providing mouse and keyboard peripheral ... fingerprint ID solutions into their product offerings, bringing ...
(Date:3/2/2015)...  Businesses have a new option for premier ... Enterprises has announced the launch of a brand ... businesses to protect their customers, personal data, as ... Beconux is a biometric transaction processing system recently ... an ATM machine, the new system fuses multiple ...
(Date:3/2/2015)... --  Neurotechnology , a provider of high-precision biometric, robotics ... Development Kit (SDK). The SentiGaze algorithm enables designers ... to track eye movements and generate heatmaps based on ... be used for applications such as analysis of websites ... can also be used to develop interfaces for a ...
Breaking Biology News(10 mins):Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Personal Data Protection Company Launches New Product 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
... has been discovered by a research group at the Sahlgrenska ... an insidious form of glandular cancer usually in the head ... discovery could lead to quicker and better diagnosis and more ... prestigious scientific journal Proceedings of the National Academy of ...
... animals and plants developed different genetic programs for cell ... one at the Swedish University of Agricultural Sciences, has ... programmed cell death in plants and animals are actually ... The findings were published in Nature Cell Biology ...
... in electronics applications, Kansas State University engineers made a ... Berry is a K-State assistant professor of chemical engineering ... single atom thick and discovered just five years ago. ... electronics properties -- Berry and Kabeer Jasuja, a K-State ...
Cached Biology News:New cancer gene discovered 2Cell death occurs in the same way in plants, animals and humans 224-carat gold 'snowflakes' improve graphene's electrical properties 2
Immunogen: Tissue / cell preparation. (Murine EHS laminin preparation) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human/Mouse APLP-1 MAb (Clone 354020) ENTREZ GeneID: 333...
Mouse monoclonal [4i97] to HLA Class 1 A25 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 1 Antigen-A25. Swiss Protein ID: P18462...
... choice of Printing Surface (3 glass slides coated with ... 1 silicon wafer coated with 1000 Angstroms of Gold ... and PDMS Stamps (3 PDMS micropatterned stamps with series ... x 10 mm or 200 um x 10 mm ...
Biology Products: